Details of the Drug Reposition

General Information of This Drug (ID: DM7F90R)

• Drug Name: SRF231 (DM7F90R)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Haematological malignancy	DISCDP7W	2B33.Y	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)